Author | Year | Region | Study category | Reagents | Samples | Method | Pre-chemo | Post-chemo | Ref. | ||
Mutation | Total | Mutation | Total | ||||||||
Munfus-McCray D | 2013 | US | Retrospective | Platinum-based third-generation doublets | Tissue | PCR | 31 17 | 37 26 | 6 9 | 37 26 | [9] |
Hua Bai | 2012 | China | Retrospective | Cisplatin and carboplatin + gemcitabine, vinorelbine and taxanes | Blood Tissue | DHPLC ARMS | 91 22 | 264 63 | 61 12 | 264 63 | [8] |
Rubing HAN | 2011 | China | Retrospective | Cisplatin/arboplatin + gemcitabine/pemetrexed/VP-16/taxanes | Serum | Nested PCR | 13 | 33 | 18 | 33 | [10] |
Hong-Gang Ke | 2013 | China | Retrospective | Pemetrexed + cisplatin | Tissue | PCR | 61 | 107 | 70 | 107 | [11] |
Yan-E Ma | 2013 | China | Retrospective | Cisplatin/carboplatin + gemcitabine/vinorelbine/pemetrexed | Plasma | DHPLC | 18 | 60 | 15 | 60 | [12] |
Shuhang Wang | 2012 | China | Retrospective | Cisplatin/carboplatin + gemcitabine/taxanes | Tissue | ARMS | 22 | 66 | 12 | 66 | [13] |